Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Trend Of Outsourcing Trials to China, India Raises New Ethics Questions

This article was originally published in PharmAsia News

Executive Summary

The trend by multinational pharmaceutical companies conducting clinical trials in China, India and other nations with emerging economies may be upsetting accepted ethics of trials. Viral Genetics, a U.S. biotech, came under criticism when it conducted a trial of an AIDS drug in China by giving a control group a placebo instead of antiretrovirals, the accepted trial behavior in the Western World. Chinese authorities investigated after several AIDS patients died during the trial, and concluded "no serious violation of ethical principles." That incident highlights increasing concerns over quality, research ethics and lives of patients in outsourced trials. (Click here for more - may require a subscription
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC066779

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel